Q2 2016 13F Holders as of 6/30/2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
44.8M
-
Number of holders
-
372
-
Total 13F shares, excl. options
-
49.3M
-
Shares change
-
-1.16M
-
Total reported value, excl. options
-
$5.22B
-
Value change
-
-$126M
-
Put/Call ratio
-
0.98
-
Number of buys
-
181
-
Number of sells
-
-188
-
Price
-
$105.92
Significant Holders of UNITED THERAPEUTICS Corp - Common Stock (UTHR) as of Q2 2016
447 filings reported holding UTHR - UNITED THERAPEUTICS Corp - Common Stock as of Q2 2016.
UNITED THERAPEUTICS Corp - Common Stock (UTHR) has 372 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 49.3M shares
.
Largest 10 shareholders include SCOPIA CAPITAL MANAGEMENT LP (4.3M shares), FMR LLC (4.06M shares), VANGUARD GROUP INC (3.63M shares), BlackRock Fund Advisors (2.22M shares), AJO, LP (2.14M shares), STATE STREET CORP (1.97M shares), Palo Alto Investors, LLC (1.72M shares), AQR CAPITAL MANAGEMENT LLC (1.58M shares), BlackRock Institutional Trust Company, N.A. (1.51M shares), and DEUTSCHE BANK AG\ (1.43M shares).
This table shows the top 372 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.